AI-ADL: a relevant tool for assessing the burden of adult acne

  • 5min
  • May. 2022
  • Supported by
  • La Roche-Posay
For decades, acne has been considered as a skin condition that mainly affects adolescents. However, it may persist into or even start in adulthood, with a 60% prevalence of acne reported in women aged 20–29 years. It is not only a chronic and potentially disfiguring condition, but acne also impacts the patient’s and cohabitant’s quality of life (QoL). This impact includes signs and symptoms of depression, anxiety and anger, as well as poor sleep quality and low self-esteem. The importance of its psychological impact has been shown to be linked with the severity of the condition, being somewhat more important in female than in male subjects. Recently, a novel burden questionnaire (Impact of acne on the daily life of adults : AI-ADL) was developed to assess the burden of acne in adult patients. Its short format allows the patient to express their perception of their acne easily and quickly, and to facilitate exchanges between practitioner and patient.